statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors PR Newswire WALTHAM...

Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors

Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference PR Newswire...

Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference

Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical...

Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire WALTHAM, Mass...

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024 Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and...

Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024

Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum PR Newswire WALTHAM, Mass., April...

Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum

Syndax Presents Positive Pediatric Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary Session Syndax Presents Positive Pediatric Data from...

Syndax Presents Positive Pediatric Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary Session

This is a Bullish indicator signaling SNDX's price could rise from here. Traders may explore going long the stock or buying call options...

Syndax Pharmaceuticals (SNDX, $23.76) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 1, 2024

This is a signal that SNDX's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Syndax Pharmaceuticals (SNDX, $23.76) Stochastic Oscillator left the overbought zone on April 01, 2024

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.

Watchers	2,139
52-Wk Low	$11.22
52-Wk High	$25.34

Volume	992,762.00
52-Wk High	$25.34
52-Wk Low	$11.22

SNDX Syndax Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community